Annual short term debt:
$40.60M-$161.50M(-79.91%)Summary
- As of today (September 17, 2025), NBIX annual short term debt is $40.60 million, with the most recent change of -$161.50 million (-79.91%) on December 31, 2024.
- During the last 3 years, NBIX annual short term debt has risen by +$24.10 million (+146.06%).
- NBIX annual short term debt is now -90.27% below its all-time high of $417.09 million, reached on December 31, 2019.
Performance
NBIX Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$50.70M+$5.10M(+11.18%)Summary
- As of today (September 17, 2025), NBIX quarterly short term debt is $50.70 million, with the most recent change of +$5.10 million (+11.18%) on June 30, 2025.
- Over the past year, NBIX quarterly short term debt has increased by +$15.30 million (+43.22%).
- NBIX quarterly short term debt is now -88.34% below its all-time high of $434.70 million, reached on September 30, 2020.
Performance
NBIX quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NBIX Short term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -79.9% | +43.2% |
3 y3 years | +146.1% | +196.5% |
5 y5 years | -90.3% | -88.2% |
NBIX Short term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -79.9% | +146.1% | -82.8% | +196.5% |
5 y | 5-year | -90.3% | +294.2% | -88.3% | +392.2% |
alltime | all time | -90.3% | >+9999.0% | -88.3% | >+9999.0% |
NBIX Short term debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $50.70M(+11.2%) |
Mar 2025 | - | $45.60M(+12.3%) |
Dec 2024 | $40.60M(-79.9%) | $40.60M(+16.7%) |
Sep 2024 | - | $34.80M(-1.7%) |
Jun 2024 | - | $35.40M(-88.0%) |
Mar 2024 | - | $294.00M(+45.5%) |
Dec 2023 | $202.10M(+8.2%) | $202.10M(+7.7%) |
Sep 2023 | - | $187.70M(+0.2%) |
Jun 2023 | - | $187.40M(+918.5%) |
Mar 2023 | - | $18.40M(-90.1%) |
Dec 2022 | $186.80M(+1032.1%) | $186.80M(+0.2%) |
Sep 2022 | - | $186.50M(+990.6%) |
Jun 2022 | - | $17.10M(+1.2%) |
Mar 2022 | - | $16.90M(+2.4%) |
Dec 2021 | $16.50M(+60.2%) | $16.50M(+6.5%) |
Sep 2021 | - | $15.50M(+3.3%) |
Jun 2021 | - | $15.00M(+23.0%) |
Mar 2021 | - | $12.20M(+18.4%) |
Dec 2020 | $10.30M(-97.5%) | $10.30M(-97.6%) |
Sep 2020 | - | $434.70M(+1.4%) |
Jun 2020 | - | $428.70M(+4771.6%) |
Mar 2020 | - | $8.80M(-97.9%) |
Dec 2019 | $417.09M(>+9900.0%) | $417.09M(+5012.0%) |
Sep 2019 | - | $8.16M(+117.6%) |
Jun 2019 | - | $3.75M(+14.8%) |
Mar 2019 | - | $3.27M(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(-100.0%) |
Sep 2018 | - | $383.65M(>+9900.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00 | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2008 | - | $276.00K(-54.1%) |
Jun 2008 | - | $601.00K(-41.4%) |
Mar 2008 | - | $1.02M(-31.0%) |
Dec 2007 | $1.49M(-66.9%) | $1.49M(-44.8%) |
Sep 2007 | - | $2.69M(-17.7%) |
Jun 2007 | - | $3.27M(-15.6%) |
Mar 2007 | - | $3.88M(-13.6%) |
Dec 2006 | $4.49M(-22.8%) | $4.49M(-7.7%) |
Sep 2006 | - | $4.86M(-7.3%) |
Jun 2006 | - | $5.25M(-5.4%) |
Mar 2006 | - | $5.55M(-4.6%) |
Dec 2005 | $5.81M(-12.9%) | $5.81M(-3.9%) |
Sep 2005 | - | $6.05M(-2.9%) |
Jun 2005 | - | $6.23M(-3.5%) |
Mar 2005 | - | $6.46M(-3.2%) |
Dec 2004 | $6.67M(+68.5%) | $6.67M(+40.4%) |
Sep 2004 | - | $4.75M(+20.4%) |
Jun 2004 | - | $3.95M(-2.2%) |
Mar 2004 | - | $4.03M(+1.9%) |
Dec 2003 | $3.96M(+49.0%) | $3.96M(+15.7%) |
Sep 2003 | - | $3.42M(+2.3%) |
Jun 2003 | - | $3.34M(+13.8%) |
Mar 2003 | - | $2.94M(+10.6%) |
Dec 2002 | $2.66M(+27.4%) | $2.66M(+19.9%) |
Sep 2002 | - | $2.22M(+13.3%) |
Jun 2002 | - | $1.96M(+3.7%) |
Mar 2002 | - | $1.89M(-9.6%) |
Dec 2001 | $2.09M(+31.5%) | $2.09M(+23.2%) |
Sep 2001 | - | $1.69M(-2.7%) |
Jun 2001 | - | $1.74M(+12.5%) |
Mar 2001 | - | $1.55M(-2.5%) |
Dec 2000 | $1.59M(+62.9%) | $1.59M(+38.4%) |
Sep 2000 | - | $1.15M(+14.0%) |
Jun 2000 | - | $1.01M(+1.6%) |
Mar 2000 | - | $990.00K(+1.6%) |
Dec 1999 | $974.00K(+15.7%) | $974.00K(+5.8%) |
Sep 1999 | - | $921.00K(-6.6%) |
Jun 1999 | - | $986.00K(-34.1%) |
Mar 1999 | - | $1.50M(+77.8%) |
Dec 1998 | $842.00K(-3.5%) | $842.00K(-78.5%) |
Sep 1998 | - | $3.92M(+40.3%) |
Jun 1998 | - | $2.79M(-35.6%) |
Mar 1998 | - | $4.33M(+381.4%) |
Dec 1997 | $872.60K(+11.3%) | $900.00K(+12.5%) |
Dec 1996 | $783.70K | $800.00K(0.0%) |
Mar 1996 | - | $800.00K |
FAQ
- What is Neurocrine Biosciences, Inc. annual short term debt?
- What is the all time high annual short term debt for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual short term debt year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly short term debt?
- What is the all time high quarterly short term debt for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly short term debt year-on-year change?
What is Neurocrine Biosciences, Inc. annual short term debt?
The current annual short term debt of NBIX is $40.60M
What is the all time high annual short term debt for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual short term debt is $417.09M
What is Neurocrine Biosciences, Inc. annual short term debt year-on-year change?
Over the past year, NBIX annual short term debt has changed by -$161.50M (-79.91%)
What is Neurocrine Biosciences, Inc. quarterly short term debt?
The current quarterly short term debt of NBIX is $50.70M
What is the all time high quarterly short term debt for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly short term debt is $434.70M
What is Neurocrine Biosciences, Inc. quarterly short term debt year-on-year change?
Over the past year, NBIX quarterly short term debt has changed by +$15.30M (+43.22%)